Johnson & Johnson Stock at $234: Can Oncology Growth Justify the 2026 Guidance Raise?
If Johnson & Johnson’s oncology segment sustains double-digit growth over the next 12 months, the current $234.2 stock price (per Yahoo Finance, as of…